Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000950170-24-074284

President & CEO sold 8,625 shares at an average $141.85 ($1,223,473)

  • President & CEO acquired 8,625 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hassanein Waleed H · President & CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-14 Exercise or conversion : show line 1 in the form 10b5-1 +8,625 $13.28 $114,540 70,268 D
2024-06-14 Sale : show line 2 in the form 10b5-1 −1,614 $140.42 $226,638 68,654 D
2024-06-14 Sale : show line 3 in the form 10b5-1 −3,836 $141.62 $543,254 64,818 D
2024-06-14 Sale : show line 4 in the form 10b5-1 −2,675 $142.68 $381,669 62,143 D
2024-06-14 Sale : show line 5 in the form 10b5-1 −400 $143.65 $57,460 61,743 D
2024-06-14 Sale : show line 6 in the form 10b5-1 −100 $144.52 $14,452 61,643 D
Open-market sales · 8,625 sh · avg $141.85 · $1,223,473

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-14 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −8,625 130,750 D
Loading xslF345X05/ownership.xml…